| Lisa Denise Zimms, APRN | |
|
1801 W 3rd St, Elk City, OK 73644-5145 | |
| (580) 225-2511 | |
| Not Available |
| Full Name | Lisa Denise Zimms |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1801 W 3rd St, Elk City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629850532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 215547 (Oklahoma) | Primary |
| Entity Name | Farmers Union Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184639122 PECOS PAC ID: 7517949415 Enrollment ID: O20040603001383 |
News Archive
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into a license agreement with Clinuvel Pharmaceuticals Limited of Melbourne, Australia. Under the agreement, the Company's SurModics Pharmaceuticals unit has licensed certain of its biodegradable polymer implant technology to Clinuvel for the treatment of sun-induced skin disorders. Terms of the agreement were not disclosed.
H.I.G. Capital, LLC, a leading global private investment firm, today announced that it has reviewed the letter addressed to the Board of Directors of Matrixx Initiatives, Inc. from BML Capital Management, LLC, dated January 25, 2011, regarding the pending tender offer for all of the outstanding shares of common stock of Matrixx by Wonder Holdings, Inc. and Wonder Holdings Acquisition Corp., both affiliates of H.I.G. formed for the purpose of acquiring Matrixx.
Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Denise Zimms, APRN 1801 W 3rd St, Elk City, OK 73644-5145 Ph: (580) 225-2511 | Lisa Denise Zimms, APRN 1801 W 3rd St, Elk City, OK 73644-5145 Ph: (580) 225-2511 |
News Archive
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into a license agreement with Clinuvel Pharmaceuticals Limited of Melbourne, Australia. Under the agreement, the Company's SurModics Pharmaceuticals unit has licensed certain of its biodegradable polymer implant technology to Clinuvel for the treatment of sun-induced skin disorders. Terms of the agreement were not disclosed.
H.I.G. Capital, LLC, a leading global private investment firm, today announced that it has reviewed the letter addressed to the Board of Directors of Matrixx Initiatives, Inc. from BML Capital Management, LLC, dated January 25, 2011, regarding the pending tender offer for all of the outstanding shares of common stock of Matrixx by Wonder Holdings, Inc. and Wonder Holdings Acquisition Corp., both affiliates of H.I.G. formed for the purpose of acquiring Matrixx.
Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
› Verified 6 days ago
Jacob Jackson, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1800 W 1st St Ste 105b, Elk City, OK 73644 Phone: 580-225-2518 Fax: 580-225-3167 | |
Kasee Mcarthur, APRN C-NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 411 N Randall Ave, Elk City, OK 73644 Phone: 580-243-2273 | |
Alicia K Price, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1710 W 3rd St, Elk City, OK 73644 Phone: 580-225-1290 Fax: 580-225-2178 | |
Amanda Lynn Lafarlette, APRNC-NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 411 N Randall Ave, Elk City, OK 73644 Phone: 580-243-2273 Fax: 580-243-2832 | |
Joy Celsor, APRN, FNP-BC, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 209 S Jefferson Ave, Elk City, OK 73644 Phone: 580-799-5471 | |
Rubi Ann Litteral, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 411 W 3rd St, Elk City, OK 73644 Phone: 580-303-9293 Fax: 580-540-3017 | |
Katie Jane Robinson, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2406 Bell Ave, Elk City, OK 73644 Phone: 580-303-7944 Fax: 580-210-5227 |